Differences in Adverse Drug Events Among Pediatric Patients With and Without Cancer: Sub-Analysis of a Retrospective Cohort Study

por Koizumi, Akira, Ohta, Yoshinori, Sakuma, Mio, Okamoto, Rika, Matsumoto, Chisa, Bates, David W., Morimoto, Takeshi
Publicado 2017

Evaluation of amnion-derived mesenchymal stem cells for treatment-resistant moderate Crohn’s disease: study protocol for a phase I/II, dual-centre, open-label, uncontrolled, dose–r...

por Otagiri, Shinsuke, Ohnishi, Shunsuke, Miura, Arisa, Hayashi, Hiroshi, Kumagai, Izumi, Ito, Yoichi M, Katsurada, Takehiko, Nakamura, Shiro, Okamoto, Rika, Yamahara, Kenichi, Cho, Kyu Yong, Isoe, Toshiyuki, Sato, Norihiro, Sakamoto, Naoya
Publicado 2018

Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell tr...

por Yamahara, Kenichi, Hamada, Akiko, Soma, Toshihiro, Okamoto, Rika, Okada, Masaya, Yoshihara, Satoshi, Yoshihara, Kyoko, Ikegame, Kazuhiro, Tamaki, Hiroya, Kaida, Katsuji, Inoue, Takayuki, Ohsugi, Yuko, Nishikawa, Hiroki, Hayashi, Hiroshi, Ito, Yoichi M, Iijima, Hiroaki, Ohnishi, Shunsuke, Hashimoto, Daigo, Isoe, Toshiyuki, Teshima, Takanori, Ogawa, Hiroyasu, Sato, Norihiro, Fujimori, Yoshihiro
Publicado 2019